Brooke A. Pereira

ORCID: 0000-0003-3513-1214
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Cancer Cells and Metastasis
  • Neuroendocrine Tumor Research Advances
  • Epigenetics and DNA Methylation
  • Pancreatic function and diabetes
  • Ferroptosis and cancer prognosis
  • Caveolin-1 and cellular processes
  • Cellular Mechanics and Interactions
  • Amino Acid Enzymes and Metabolism
  • 3D Printing in Biomedical Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer Research and Treatments
  • Phagocytosis and Immune Regulation
  • Prostate Cancer Treatment and Research
  • Cancer Genomics and Diagnostics
  • Cell Adhesion Molecules Research
  • Proteoglycans and glycosaminoglycans research
  • Biomedical Ethics and Regulation
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Mast cells and histamine
  • Biomedical and Engineering Education
  • Microbial metabolism and enzyme function
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Immune Cell Function and Interaction

UNSW Sydney
2019-2025

Garvan Institute of Medical Research
2019-2025

The Kinghorn Cancer Centre
2019-2025

St Vincent's Clinic
2019-2023

St Vincent's Health
2023

Cancer Australia
2021

Monash University
2015-2020

Discovery Institute
2019

Claire Vennin Pauline Mélénec Romain Rouet Max Nobis Aurélie Cazet and 95 more Kendelle J. Murphy David Herrmann Daniel A. Reed Morghan C. Lucas Sean Warren Zehra Elgundi Mark Pinese Gabriella Kalna Daniel Roden Monisha Samuel Anaiis Zaratzian Shane T. Grey Andrew Da Silva Wilfred Leung Amber L. Johns Lorraine A. Chantrill Angela Chou Angela Steinmann Mehreen Arshi Tanya Dwarte Danielle Froio Brooke A. Pereira Shona Ritchie Cecilia R Chambers Xanthe Metcalf Nicola Waddell John V. Pearson Ann-Marie Patch Katia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Sean M. Grimmond Oliver Hofmann Angelika N. Christ Timothy J. C. Bruxner Jaswinder S. Samra Nick Pavlakis Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David M. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Caroline Cooper Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Krishna Epari Mo Ballal David Fletcher Sanjay Mukhedkar Nikolajs Zeps Maria Beilin Kynan Feeney Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Rita T. Lawlor Stefania Beghelli Vincenzo Corbo Maria Scardoni Claudio Bassi

Abstract Heterogeneous subtypes of cancer-associated fibroblasts (CAFs) coexist within pancreatic cancer tissues and can both promote restrain disease progression. Here, we interrogate how cells harboring distinct alterations in p53 manipulate CAFs. We reveal the existence a p53-driven hierarchy, where with gain-of-function (GOF) mutant educate dominant population CAFs that establish pro-metastatic environment for GOF null alike. also demonstrate educated by may be reprogrammed either or...

10.1038/s41467-019-10968-6 article EN cc-by Nature Communications 2019-08-12

The tumour stroma, and in particular the extracellular matrix (ECM), is a salient feature of solid tumours that plays crucial role shaping their progression. Many desmoplastic including breast cancer involve significant accumulation type I collagen. However, recently it has become clear precise distribution organisation molecules such as collagen equally important abundance. Cancer-associated fibroblasts (CAFs) coexist within tissues play both pro- anti-tumourigenic roles through remodelling...

10.1038/s41467-022-32255-7 article EN cc-by Nature Communications 2022-08-06
Jessica L. Chitty Michelle Yam Lara Perryman Amelia L. Parker Joanna N. Skhinas and 95 more Yordanos F. Setargew Ellie T. Y. Mok Emmi Tran Rhiannon D. Grant Sharissa L. Latham Brooke A. Pereira Shona Ritchie Kendelle J. Murphy Michael Trpceski Alison D. Findlay Pauline Mélénec Elysse C. Filipe Audrey Nadalini Sipiththa Velayuthar Gretel Major Kaitlin Wyllie Michael Papanicolaou Shivanjali Ratnaseelan Phoebe A. Phillips George Sharbeen Janet Youkhana Alice G. Russo Antonia Blackwell Jordan F. Hastings Morghan C. Lucas Cecilia R. Chambers Daniel A. Reed Janett Stoehr Claire Vennin Ruth Pidsley Anaiis Zaratzian Andrew M. Da Silva Michael Tayao Brett Charlton David Herrmann Max Nobis Susan J. Clark Andrew V. Biankin Amber L. Johns David R. Croucher Adnan Nagrial Anthony J. Gill Sean M. Grimmond Lorraine A. Chantrill Angela Chou Tanya Dwarte Xanthe L. Metcalf Gloria Jeong Lara Kenyon Nicola Waddell John V. Pearson Ann-Marie Patch Kátia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Amitabha Das Peter H. Cosman Kasim Ismail Alina Stoita David B. Williams Allan Spigellman Duncan McLeo Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine L. Tucker Lesley Andrews Michael Texler Cindy Forrest Mo Ballal David Fletcher Maria Beilin Kynan Feeney Krishna Epari Sanjay Mukhedkar Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen

Abstract The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance this crosslinking and stabilizing fibrillar collagens its known role tumor desmoplasia. Using small-molecule drug-design approaches, we generated validated PXS-5505, first-in-class highly selective potent pan-lysyl inhibitor. We demonstrate vitro vivo that inhibition decreases chemotherapy-induced pancreatic desmoplasia stiffness, reduces cancer cell invasion metastasis,...

10.1038/s43018-023-00614-y article EN cc-by Nature Cancer 2023-08-28

Abstract Cancer-associated fibroblasts (CAF) are major contributors to pancreatic ductal adenocarcinoma (PDAC) progression through protumor signaling and the generation of fibrosis, latter which creates a physical barrier drugs. CAF inhibition is thus an ideal component any therapeutic approach for PDAC. SLC7A11 cystine transporter that has been identified as potential target in PDAC cells. However, no prior study evaluated role tumor stroma its prognostic significance. Here we show high...

10.1158/0008-5472.can-20-2496 article EN Cancer Research 2021-05-12

In prostate cancer, cancer-associated fibroblasts (CAF) exhibit contrasting biological properties to non-malignant (NPF) and promote tumorigenesis. Resolving intercellular signaling pathways between CAF tumor epithelium may offer novel opportunities for research translation. To this end, the proteome phosphoproteome of four pairs patient-matched NPF were characterized identify discriminating proteomic signatures. Samples analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS)...

10.1074/mcp.ra119.001496 article EN cc-by Molecular & Cellular Proteomics 2019-05-07

Abstract The poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is attributed to the highly fibrotic stroma and complex multi-cellular microenvironment that difficult fully recapitulate in pre-clinical models. To fast-track translation therapies inform personalised medicine, we aimed develop a whole-tissue ex vivo explant model maintains viability, 3D multicellular architecture, microenvironmental cues human tumours. Patient-derived surgically-resected PDAC tissue was cut into 1–2 mm...

10.1038/s41598-021-81299-0 article EN cc-by Scientific Reports 2021-01-21
Vanessa Lakis Rita T. Lawlor Felicity Newell Ann‐Marie Patch Andrea Mafficini and 95 more Anguraj Sadanandam Lambros T. Koufariotis Rebecca L. Johnston Conrad Leonard Scott Wood Borislav C. Rusev Vincenzo Corbo Claudio Luchini Sara Cingarlini Luca Landoni Roberto Salvia Michèle Milella David K. Chang Peter J. Bailey Nigel B. Jamieson Fraser R. Duthie Marie‐Claude Gingras Donna M. Muzny David A. Wheeler Richard A. Gibbs Massimo Milione Lorraine A. Chantrill Paul Timpson Angela Chou Marina Pajic Angela Murphy Tanya Dwarte David Hermann Claire Vennin Thomas R. Cox Brooke A. Pereira Shona Ritchie Daniel A. Reed Cecilia R. Chambers Xanthe L. Metcalf Max Nobis Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Qinying Xu Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David B. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Mo Ballal David Fletcher Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Judith Dixon Maria Scardoni Claudio Bassi Sonia Grimaldi Cinzia Cantù Giada Bonizzato Samantha Bersani

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups PanNETs, termed T1, T2 T3, distinct patterns methylation. The T1 subgroup was enriched for functional ATRX, DAXX MEN1 wild-type genotypes. contained mutations in recurrent chromosomal losses half genome no association between regions loss levels. were larger had lower MGMT gene body, which showed positive...

10.1038/s42003-020-01469-0 article EN cc-by Communications Biology 2021-02-03

Pancreatic cancer (PC) is a highly metastatic malignancy. More than 80% of patients with PC present advanced-stage disease, preventing potentially curative surgery. The neuropeptide Y (NPY) system, best known for its role in controlling energy homeostasis, has also been shown to promote tumorigenesis range types, but yet be explored. We show that expression NPY and NPY1R are up-regulated mouse models human PC. Moreover, using the genetically engineered, autochthonous KP R172H C model PC, we...

10.1126/sciadv.adq4416 article EN cc-by-nc Science Advances 2025-03-12

Prostate cancer changes the phenotype of cells within stromal microenvironment, including fibroblasts, which in turn promote tumour progression. Functional prostate cancer-associated fibroblasts (CAFs) coincide with alterations DNA methylation levels at loci-specific regulatory regions. Yet, it is not clear how these compare across CAFs from different patients. Therefore, we examined consistency and prognostic significance genome-wide profiles between patients grades primary cancer.We used...

10.1186/s13148-020-00836-2 article EN cc-by Clinical Epigenetics 2020-03-18

The dense desmoplastic and fibrotic stroma is a characteristic feature of pancreatic ductal adenocarcinoma (PDAC), regulating disease progression, metastasis response to treatment. Reciprocal interactions between the tumour are mediated by bidirectional integrin-mediated signalling, in particular Focal Adhesion Kinase (FAK). FAK often hyperactivated overexpressed aggressive cancers, promoting stromal remodelling inducing tissue stiffness which can accelerate cancer cell proliferation,...

10.1042/bst20220162 article EN cc-by Biochemical Society Transactions 2022-08-05

Mast cells (MCs) are important cellular components of the tumor microenvironment and significantly associated with poor patient outcomes in prostate cancer other solid cancers. The promotion progression partly involves heterotypic interactions between MCs cancer-associated fibroblasts (CAFs), which combine to potentiate a pro-tumor extracellular matrix promote epithelial cell invasion migration. Thus far, CAFs remain poorly understood. To identify molecular changes that may alter resident MC...

10.3390/cancers13061237 article EN Cancers 2021-03-11

Aberrant AKT activation occurs in a number of cancers, metabolic syndrome, and immune disorders, making it an important target for the treatment many diseases. To monitor spatial temporal activity live setting, we generated Akt-FRET biosensor mouse that allows longitudinal assessment using intravital imaging conjunction with image stabilization optical window technology. We demonstrate sensitivity various cancer models verify its suitability to response drug targeting spheroid organotypic...

10.1126/sciadv.adf9063 article EN cc-by-nc Science Advances 2023-04-26

ABSTRACT Most of the techniques used for micro and nano‐patterning currently are high quality reproducibility, but they require expensive equipment involve many time‐consuming steps to achieve desired results. We herein report a patterning method conducting layers on breathable substrates using fast, simple, mask‐less laser engraving technique. A resolution in range 30 μm has been successfully achieved this report. The is fast pattern can be easily changed or redesigned within few minutes....

10.1002/app.42359 article EN Journal of Applied Polymer Science 2015-06-11
Coming Soon ...